Products
In this classification, a Beta-2-glycoprotein iii immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Beta-2-glycoprotein iii. US FDA regulates Beta-2-glycoprotein iii immunological test system under 21 CFR 866.5440 and under FDA product code DDK.
How AGI delivers it
Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.
For Beta-2-glycoprotein iii immunological test system, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.
Get the professional outcome delivered as software, priced on results, not headcount.
For Beta-2-glycoprotein iii immunological test system, get the professional outcome delivered as software, priced on results, not headcount.
Value flow
Go deeper